BioBoom fullDate time-to-read.short-label Sorrento Therapeutics...What's Next? November 27, 2020 News Recap It has been an eventful few months as it pertains to how Sorrento Therapeutics will strategically move from ...
BioBoom fullDate time-to-read.short-label Antibodies Is How We Get Back To Normal The Biotech landscape has been slowly shifting awareness to the likes of Antibodies & Therapeutics, especially after the President was t...
BioBoom fullDate time-to-read.short-label Sorrento Therapeutics On The Run Recap Sorrento Therapeutics has run over 100% since it hit bottom at $5.77. Hindenburg put out hit piece on SRNE scaring off many retail...